loadpatents
Patent applications and USPTO patent grants for Vanasse; K Gary J.The latest application filed is for "use of high-affinity, ligand-blocking, humanized anti-t-cell immunoglobulin domain and mucin domain-3 (tim-3) igg4 antibody for the treatment of myelofibrosis".
Patent | Date |
---|---|
Use Of High-affinity, Ligand-blocking, Humanized Anti-t-cell Immunoglobulin Domain And Mucin Domain-3 (tim-3) Igg4 Antibody For The Treatment Of Myelofibrosis App 20220306737 - Eliasson; Asa ;   et al. | 2022-09-29 |
Combination Therapy With Chimeric Antigen Receptor (car) Therapies App 20210213063 - Isaacs; Randi ;   et al. | 2021-07-15 |
Use Of Il-1beta Binding Antibodies App 20200369762 - BRUEDERLE; Andreas ;   et al. | 2020-11-26 |
Pim Kinase Inhibitor Combinations App 20190290627 - Cao; Zhu Alexander ;   et al. | 2019-09-26 |
Pim Kinase Inhibitor Combinations App 20170368044 - Cao; Zhu Alexander ;   et al. | 2017-12-28 |
Pim Kinase Inhibitor Combinations App 20160175293 - Cao; Zhu Alexander ;   et al. | 2016-06-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.